A detailed history of Capital Asset Advisory Services LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 3,727 shares of EW stock, worth $244,043. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,727
Previous 3,747 0.53%
Holding current value
$244,043
Previous $358,000 3.91%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$84.3 - $94.31 $1,686 - $1,886
-20 Reduced 0.53%
3,727 $344,000
Q1 2024

Apr 16, 2024

BUY
$72.54 - $95.56 $797 - $1,051
11 Added 0.29%
3,747 $358,000
Q4 2023

Jan 09, 2024

BUY
$61.71 - $77.76 $3,949 - $4,976
64 Added 1.74%
3,736 $284,000
Q3 2023

Oct 18, 2023

SELL
$69.28 - $93.38 $1,732 - $2,334
-25 Reduced 0.68%
3,672 $254,000
Q2 2023

Aug 02, 2023

SELL
$81.41 - $94.33 $1,953 - $2,263
-24 Reduced 0.64%
3,697 $348,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $25,174 - $28,648
-339 Reduced 8.35%
3,721 $307,000
Q4 2022

Mar 08, 2023

BUY
$68.3 - $87.44 $277,298 - $355,006
4,060 New
4,060 $302,000
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $439,506 - $651,739
5,081 New
5,081 $483,000
Q3 2020

Nov 18, 2020

SELL
$67.19 - $87.44 $703,479 - $915,496
-10,470 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $602,443 - $805,666
10,470 New
10,470 $803,000
Q1 2020

May 18, 2020

SELL
$52.41 - $81.0 $187,889 - $290,385
-3,585 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $249,157 - $285,262
3,475 Added 3159.09%
3,585 $829,000
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $243,780 - $279,106
-3,400 Reduced 96.87%
110 $836,000
Q3 2019

Oct 10, 2019

SELL
$61.55 - $75.43 $1,846 - $2,262
-30 Reduced 0.85%
3,510 $772,000
Q4 2018

Jan 31, 2019

SELL
$46.41 - $56.94 $696 - $854
-15 Reduced 0.42%
3,540 $542,000
Q3 2018

Jan 31, 2019

SELL
$45.7 - $58.03 $2,285 - $2,901
-50 Reduced 1.39%
3,555 $619,000
Q2 2018

Jul 11, 2018

SELL
$42.45 - $51.3 $18,041 - $21,802
-425 Reduced 10.55%
3,605 $525,000
Q1 2018

May 16, 2018

SELL
$37.19 - $47.45 $1,301 - $1,660
-35 Reduced 0.86%
4,030 $562,000
Q4 2017

Jan 11, 2018

SELL
$33.79 - $39.39 $21,794 - $25,406
-645 Reduced 13.69%
4,065 $458,000
Q3 2017

Oct 30, 2017

BUY
$36.29 - $38.83 $170,925 - $182,889
4,710
4,710 $515,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.